On August 4, 2022, Pieris Pharmaceuticals, Inc. (together with its wholly-owned subsidiary, Pieris Pharmaceuticals GmbH, the Company) announced that Tim Demuth, M.D., Ph.D. has mutually agreed with the Company to step down effective September 30, 2022. Dr. Demuth had served as Pieris' Senior Vice President and Chief Medical Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.99 USD | -1.73% | -3.37% | -24.54% |
Apr. 19 | Pieris Pharmaceuticals Shares Fall After 1-for-80 Reverse Stock Split Announcement | MT |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-24.54% | 13.59M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.93% | 21.97B | |
-5.24% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- PIRS Stock
- News Pieris Pharmaceuticals, Inc.
- Pieris Pharmaceuticals, Inc. Announces Tim Demuth Steps Down as Senior Vice President and Chief Medical Officer, Effective September 30, 2022